Caladrius Biosciences, Inc. (CLBS) financial statements (2020 and earlier)

Company profile

Business Address 110 ALLEN ROAD
BASKING RIDGE, NJ 07920
State of Incorp. DE
Fiscal Year End December 31
SIC 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:233852472246
Cash and cash equivalents1410 15201946
Short-term investments  26  7 
Other undisclosed cash, cash equivalents, and short-term investments92826(10)(13)(4) 
Restricted cash and investments     15 
Receivables  03332
Inventory, net of allowances, customer advances and progress billings      1
Inventory      1
Prepaid expense and other current assets2
Other undisclosed current assets3691720(4) 
Total current assets:26446125293651
Noncurrent Assets
Property, plant and equipment00017171613
Intangible assets, net (including goodwill)   9107325
Goodwill   772511
Intangible assets, net (excluding goodwill)   234814
Other noncurrent assets101111 
Prepaid expense and other noncurrent assets1
Other undisclosed noncurrent assets  1    
Total noncurrent assets:10227289039
TOTAL ASSETS:274563525712690
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities669  107
Accounts payable111  63
Accrued liabilities458  44
Debt  0  11
Derivative instruments and hedges, liabilities      0
Deferred revenue and credits   42
Other undisclosed current liabilities   20211 
Total current liabilities:66920211610
Noncurrent Liabilities
Long-term debt and lease obligation   311141
Long-term debt, excluding current maturities   311141
Liabilities, other than long-term debt12461195
Deferred revenue and credits 5   
Deferred tax liabilities, net  11184
Other liabilities1240111
Other undisclosed noncurrent liabilities   20223522
Total noncurrent liabilities:12428346828
Other undisclosed liabilities   (0)(21)(16)(10)
Total liabilities:771348346828
Stockholders' equity
Stockholders' equity attributable to parent2138515245963
Preferred stock  00000
Common stock0000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital439436433410396350300
Accumulated other comprehensive income (loss)0(0)(0) 00 
Accumulated deficit(417)(398)(382)(405)(372)(291)(236)
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(1)(0)(0)(1)
Total stockholders' equity:2137504235862
TOTAL LIABILITIES AND EQUITY:274563525712690

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues  235221815
Revenue, net2    
Cost of revenue   (31)(20)(16)(13)
Gross profit:  24222
Operating expenses(20)(17)(28)(67)(136)(76)(39)
Other undisclosed operating income (loss)  (2)312016 
Operating loss:(20)(17)(28)(31)(114)(58)(37)
Nonoperating income (expense)11(0)(2)162(2)
Other nonoperating income (expense)1100183(2)
Interest and debt expense (0)(0)(2)(2)(1)(0)
Loss from continuing operations before equity method investments, income taxes:(19)(16)(28)(35)(100)(56)(39)
Other undisclosed income from continuing operations before income taxes 002210
Loss from continuing operations before income taxes:(19)(16)(28)(33)(98)(56)(39)
Income tax expense (benefit)  12(0)170(1)
Loss from continuing operations:(19)(16)(16)(33)(81)(55)(39)
Income from discontinued operations  38    
Net income (loss):(19)(16)22(33)(81)(55)(39)
Other undisclosed net income (loss) attributable to parent(0)01  11
Net income (loss) attributable to parent:(19)(16)23(33)(81)(55)(39)
Other undisclosed net income available to common stockholders, basic   10  
Net income (loss) available to common stockholders, diluted:(19)(16)23(33)(81)(55)(39)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(19)(16)22(33)(81)(55)(39)
Other comprehensive income (loss)0(0)(0)(0)(0)0 
Comprehensive income (loss):(19)(16)22(33)(81)(55)(39)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)0110(1)(1)
Other undisclosed comprehensive income, net of tax, attributable to parent     11
Comprehensive income (loss), net of tax, attributable to parent:(19)(16)23(33)(81)(55)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: